BPA Call 15DDHQ24A00000008-15DDHQ26F00000692
- Not listed
- The Drug Enforcement Administration issued a BPA call to The Mclean Hospital Corporation under the DEA Blanket Purchase Agreement (established May 1, 2024, five-year ceiling of $1,062,961.53 through April 30, 2029) on July 14, 2026, for benzodiazepine testing with a call value of $134,311.86. The parent BPA is a single-award, indefinite delivery, indefinite quantity vehicle enabling the DEA to issue task orders for specialized scientific expertise in monitoring and regulating controlled...
- The Department of Justice Drug Enforcement Administration (DEA) awarded a $136,383.00 firm fixed price purchase order to The Mclean Hospital Corporation, a non-profit research hospital affiliated with Harvard Medical School, to conduct a study on the drug discrimination and locomotor activity of 15 designer benzodiazepine substances. This study aims to gather pharmacological, medical, and epidemiological data to support the DEA's efforts to place these substances under regulatory control under...
- <p>The Drug Enforcement Administration issued a BPA call to Guidehouse Inc. on September 12, 2024, with a ceiling value of $30,543,425.87 under the DEA Program Management Support BPA. The call covers IT and instructor support services. Place of performance is West McLean, Virginia. The period of performance runs from September 12, 2024, through September 11, 2029. Work is procured on a labor-hour pricing basis.</p>
- The Drug Enforcement Administration issued a BPA call to XL Associates, Inc. under the $91.95 million DEA Blanket Purchase Agreement (BPA) with a ceiling value of $2,340,819.67 and an award date of August 30, 2025. The call covers professional, technical, and administrative support services. Performance occurs in Vienna, Virginia, with a period of performance from August 30, 2025 through August 29, 2026. The call was issued without a set-aside designation and carries firm fixed price pricing.
- This BPA call order awarded by the Department of Justice Drug Enforcement Administration to the University of North Texas Health Science Center at Fort Worth is for $94,095.47 to conduct pharmacological testing and evaluation of abuse potential of synthetic opioids using in vivo pharmacological studies. The order was placed against BPA number 15DDHQ19A00000016 and has a completion date of January 30, 2023. As the award does not have a set-aside designation, it is an unrestricted order. The place...
- The Drug Enforcement Administration issued a BPA call to Reel Impact, Inc. valued at one million dollars, effective October 1, 2023 through September 30, 2024, under the DEA Blanket Purchase Agreement 15DDHQ21A00000026, a five million dollar single-award BPA awarded October 1, 2021 and extending through September 30, 2026. The BPA is designated Total Small Business and supports conference live streaming, recording, webinar facilitation, and training event production for DEA regulatory compliance...
- The Drug Enforcement Administration awarded a Blanket Purchase Agreement (BPA) call order to The DEA Education Foundation for Operation Engage Programming 2026, valued at $80,149.34. This firm fixed-price contract was issued on March 27, 2026, and will be performed in Wakefield, Massachusetts, with a period of performance extending from March 31, 2026, through December 31, 2026, and an ultimate completion date of March 26, 2027. The contract was awarded without a set-aside designation,...
- The Drug Enforcement Administration issued a BPA call to Ardelle Associates, Inc., a veteran-owned small business, on June 1, 2025, under a blanket purchase agreement with a ceiling value of $1,431,935.04. The call is set aside for total small business. Performance is at West Springfield, Virginia, from May 5, 2025 through May 4, 2026, with an ultimate completion date of May 31, 2026. Work is priced on a labor-hours basis and includes professional staffing and administrative support services....
- <p>The Drug Enforcement Administration issued a BPA call to XL Associates, Inc. on May 5, 2026, valued at $3,992,601.60 under the DEA's $91.95 million Blanket Purchase Agreement (BPA with XLA through February 2030).</p> <p>The call covers professional, technical, and administrative support services on a labor-hour pricing basis. Work is performed in Vienna, Virginia. The period of performance runs from May 5, 2026 through May 4, 2027. No set-aside was applied to this call.</p>
- <p>The Drug Enforcement Administration issued a BPA call to XL Associates, Inc. under the DEA's $91.95 million single-award Blanket Purchase Agreement (reference 15DDHQ25A00000007) with a ceiling value of $1,071,369.60 and an award date of September 1, 2026. The call funds public affairs support services on a labor-hour pricing basis. Place of performance is Vienna, Virginia. The period of performance runs from September 1, 2026 through August 31, 2027. No set-aside applied to this call.</p>
- 15DDHQ24A00000008Blanket Purchase Agreement
- 15DDHQ24A00000008-15DDHQ26F00000692BPA Call
The Drug Enforcement Administration issued a BPA call to The Mclean Hospital Corporation for depressants testing, valued at $144,495.86, with an award date of September 1, 2026. The call is issued under the DEA Blanket Purchase Agreement established May 1, 2024, with a five-year ceiling of $1,062,961.53 through April 30, 2029. The BPA provides indefinite delivery and indefinite quantity services for specialized scientific expertise in monitoring and regulating controlled substances, regulated chemicals, and emerging drugs. Place of performance is Belmont, Massachusetts. The call's ultimate completion date is August 31, 2027. Work involves depressants testing as part of the DEA's substance monitoring and regulatory science mission. Pricing is firm fixed price. No set-aside applies. McLean Hospital is a non-profit psychiatric teaching hospital affiliated with Harvard Medical School with substantial prior DEA contract experience in controlled substance assessment and benzodiazepine testing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $144.5k | 7/23/26 |